Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/6380Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Semwal, Jayanti [et al.] | - |
| dc.date.accessioned | 2026-08-06T06:32:19Z | - |
| dc.date.available | 2026-08-06T06:32:19Z | - |
| dc.date.issued | 2026-06 | - |
| dc.identifier.issn | 0019-557X | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/6380 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Wolters Kluwer | en_US |
| dc.subject | Chemoimmunotherapy, chemotherapy, epidermal growth factor receptor tyrosine kinase inhibitors, India, lung cancer treatment, nonsmall cell lung cancer, randomized controlled trials, targeted therapy | en_US |
| dc.title | A Scoping review to evaluate different treatments used in advanced nonsmall-cell lung cancer in India | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Vol-70,No.-2 (Apr-Jun) 2026 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.